Drug recall · June 17, 2026
Minocycline Hydrochloride Extended-Release Tablets recall
Why: Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-644-30
- Lots / codes
Lot# 25141635, Exp 4/30/2028
- Quantity
- 360 30-count bottles
- Company
- Ascend Laboratories, LLC, Bedminster, NJ
- Distribution
- Nationwide in the USA
- Initiated
- June 1, 2026 · Voluntary: Firm initiated
- Classified
- June 17, 2026
- Reported
- June 17, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Minocycline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.